Science Friday's Ira Flatow is joined by Dr. Nolan Williams, associate professor of psychiatry and behavioral sciences at Stanford University, where he’s also the director of the Stanford Brain Stimulation Lab. They talk about the advances that Williams’ team made with their #SAINT therapy (Stanford Accelerated Intelligent Neuromodulation Therapy), patient experiences with the technology, and potential future applications of this technique: https://lnkd.in/gKEBhEp5
Magnus Medical
医疗设备制造业
Burlingame,California 3,651 位关注者
We are creating the next generation of neuromodulation technology to improve quality of life rapidly and effectively.
关于我们
Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT? Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.
- 网站
-
https://www.magnusmed.com
Magnus Medical的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Burlingame,California
- 类型
- 私人持股
- 领域
- mental health和brain health
地点
-
主要
Old Bayshore Hwy
US,California,Burlingame,94010
Magnus Medical员工
动态
-
Mental Health Statistics (source: NAMI.org): -1 in 5 U.S. adults experiences mental illness each year -1 in 20 U.S. adults experiences serious mental illness each year -1 in 6 U.S. youth aged 6-17 experiences a mental health condition each year -In 2023, 53.9% of U.S. adults with mental illness received treatment At Magnus Medical, we are proud to offer people with mental illnesses the SAINT neuromodulation system, which identifies the optimal therapy target in each person’s brain by using breakthrough algorithms with structural and functional MRI for precise, personalized treatment. Learn more: https://www.magnusmed.com/
-
-
As we wrap up National Suicide Prevention and Awareness Month, we emphasize the critical role of brain health in our overall well-being. Let’s keep the conversation going about mental wellness, self-care, and the importance of seeking help. Together, we can build a supportive community that prioritizes brain health and empowers everyone to thrive. If you or someone you know is struggling or in crisis, help is available. Call or text the free, 24/7 National Suicide Prevention Hotline at 988.
-
-
Thank you, Medical Device Network, for this article on our positive results from a study investigating the durability of SAINT neuromodulation system’s anti-depressant effect in patients with treatment-resistant depression, demonstrating year-long sustained clinical benefits. The data, presented at the 2024 NYC Neuromodulation Conference held from 1 to 3 August, is the “first longer-term data” from the transcranial magnetic stimulation device, SAINT. https://lnkd.in/gufYchYg
Magnus Medical tout positive long-term data for neuromodulation system
medicaldevice-network.com
-
Congratulations MUSC (Medical University of South Carolina) for implementing SAINT therapy! Check out this new article with Dr. Brandon Bentzley, MD, PhD, Christian Gormsen, and more discussing SAINT to "provide rapid relief for people whose deep depression has been untouched by drugs or psychotherapy. And it takes less than a week." Full article: https://lnkd.in/gVqYRBnP
Quicker, more intense brain stimulation begun at MUSC shows success in depression
postandcourier.com
-
Dr. Nolan Williams, associate professor within the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and director of the Stanford Brain Stimulation Lab, sits down with Tim Ferriss to discuss many cutting-edge treatments and new technologies, including SAINT? therapy. Read the full article here: https://lnkd.in/eEr8Ma4N
-
Thank you to Dr. Amy Grooms of UAMS Psychiatric Research Institute for her insightful presentation on our SAINT neuromodulation system. SAINT?identifies the optimal therapy target in each person’s brain by using breakthrough algorithms with structural and functional MRI for precise, personalized treatment. By precisely stimulating a person’s identified target with a specialized, non-invasive pattern of repetitive magnetic pulses, SAINT effectively modifies activity in brain networks related to major depression and restores mood balance. Learn more: https://www.magnusmed.com/
-
-
TJ Ford, Field Clinical Engineer at Magnus Medical and Andrew Geoly from the Stanford Brain Stimulation Lab presented new clinical data on groundbreaking SAINT? Therapy at the 2024 NYC Neuromodulation Conference. SAINT therapy works by leveraging structural and functional magnetic resonance imaging (MRI) scans to inform a proprietary algorithm that pinpoints the optimal anatomical target for precise neurostimulation in individuals with major depression. The innovative treatment is performed on an accelerated, five-day timeline, ensuring that stimulation targeting is meticulously customized to each person’s unique brain connectivity. Read the 12 Month Sustained Remission poster here: https://lnkd.in/gC6WG-h8
-
-
Congratulations to Tim Ferriss on his 10th anniversary show! Watch this full Tim Ferriss Show episode here: https://lnkd.in/eiysq28p *SAINT is FDA-cleared to treat major depressive disorder in the US
-
We are proud to announce promising new clinical data on SAINT? therapy at the 2024 NYC Neuromodulation Conference, Aug 1-3. The research will be presented in two posters demonstrating the long-lasting benefits of SAINT treatment and its potential for personalized continuation therapy in people with treatment-resistant depression (TRD). “We’re excited to share these new findings at this year’s NYC Neuromodulation Conference, which further validate the transformative potential of the SAINT therapy in providing durable relief for people with debilitating intractable depression and offering a pathway for personalized continuation treatment to maintain remission,” said Brandon Bentzley, M.D., Ph.D., co-founder and CSO, Magnus Medical. “The potential life-saving impact is truly inspiring. Read press release: https://lnkd.in/gpGCYK7v
-